What is it about?

This commentary provides my overall opinion regarding the impact of obstructive sleep apnoea and its treatment in patients with Type 2 diabetes

Featured Image

Why is it important?

Obesity is a common risk factor for Type 2 diabetes and obstructive sleep apnoea. Hence, many studies showed a high prevalence of obstructive sleep apnoea in patients with Type 2 diabetes, In addition, obstructive sleep apnoea has been shown to be a risk factor for developing Type 2 diabetes. However, it remains unclear whether treating obstructive sleep apnoea can reduce the risk of developing Type 2 diabetes or reduce the burden of Type 2 diabetes in patients who already have the disease. It is important to understand how to diagnose and the consequences of having obstructive sleep apnoea in patients with Type 2 diabetes or pre-diabetes

Perspectives

This publication represents my interpretations of the available evidence regarding obstructive sleep apnoea in patients with Type 2 Diabetes. But this is a rapidly evolving field and several ongoing trials will make it clearer regarding the consequences of obstructive sleep apnoea and the impact of its treatment in patients with Type 2 diabetes.

Abd Tahrani

Read the Original

This page is a summary of: Obstructive sleep apnoea in diabetes: Does it matter?, Diabetes and Vascular Disease Research, June 2017, SAGE Publications,
DOI: 10.1177/1479164117714397.
You can read the full text:

Read

Contributors

The following have contributed to this page